RaviAnanthanarayanan
Stories by RaviAnanthanarayanan
India’s Tata Steel Europe JV hits roadblock, but it is not a deal-breaker
The opposition from some Thyssenkrupp investors, which may be causing concern, is on the structure of the deal.
Fortis board mulls three different bids, no lucky break in sight
Three offers are on the table now. The valuation of a Fortis share does not materially vary in the offers, but the deal structures are very different.
Fosun-Gland Pharma: The Chinese flag goes up
Is a 74% stake in Chinese hands really that different from an 86.1% stake?
India: Aurobindo Pharma buys Generis in a bid to boost margins in Europe
Aurobindo is paying €135million, or Rs 970 crore, to acquire Generis, a generic drug company, valuing it at 2 times revenue and 10.6 times Ebitda. A
India: Tata Steel sells Scunthorpe asset for a song, stock dips
News that Tata Steel Ltd may have sold its European long products business, possibly for less than the price of a cup of coffee, did little to cheer i
